Form 4: UnitedHealth Group Director Acquires Additional Shares Through Dividend Equivalents

John H. Noseworthy, a director at UnitedHealth Group, acquired 22 shares of common stock through dividend equivalents on June 25, 2024.

Summary

• On June 25, 2024, John H. Noseworthy, a director of UnitedHealth Group, acquired 22 shares of common stock.
• The acquisition was a result of dividend equivalents paid on vested deferred stock units.
• These dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.
• Following the transaction, Noseworthy directly owns 4,979 shares of UnitedHealth Group common stock.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of shares through dividend equivalents indicates a continued investment in the company by a director.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired through dividend equivalents.

Key Dates